Evervac: phase I/II study of immunogenicity and safety of a new adjuvant-free TBE vaccine cultivated in Vero cell culture

• Main Authors: Mikhail F. Vorovitch (Author), Karina G. Grishina (Author), Viktor P. Volok (Author), Liubov L. Chernokhaeva (Author), Konstantin V. Grishin (Author), Galina G. Karganova (Author), Aidar A. Ishmukhametov (Author)
• Format: Bog
• Udgivet: Taylor & Francis Group, 2020-09-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Approximately 10,000 cases of tick-borne encephalitis (TBE), a serious disease of the central nervous system caused by tick-borne encephalitis virus (TBEV), are registered worldwide every year. Vaccination against TBE remains the most essential measure of preventing the disease. Unlike available TBE...